Abstract
Probucol was effective in lowering serum total cholesterol in mice at dietary levels as low as 0.0075%. It was also effective after a single 100 mg/kg I.V. dose in mice. The incorporation of acetate-14C into liver lipids of rats and mice was not significantly affected by probucol, although the results, especially in mice, make it impossible to rule out such an effect. Cholesterol absorption was estimated in rats using a dual isotope technique. The observed reductions were not statistically significant. Several liver enzyme activities were determined after probucol treatment in rats, and a significant elevation (32%) was observed in only one, glutamic dehydrogenase. Serum cholesterol was lowered markedly in cholesterol-fed cynomolgus monkeys by probucol. There was no effect on the excretion of neutral steroids and the observed increase in fecal bile acids after drug treatment could not be confirmed statistically.
Similar content being viewed by others
References
Neuworth, M.B., R.J. Laufer, J.W. Barnhart, J.A. Sefranka, and D.D. McIntosh, J. Med. Chem. 13:722 (1970).
Barnhart, J.W., J.A. Sefranka, and D.D. McIntosh, Am. J. Clin. Nutr. 23:1229 (1970).
Drake, J.W., R.H. Bradford, M. McDearman, and R.H. Furman, Metabolism 18:916 (1969).
Harris, R.S., H.R. Gilmore, L.A. Bricker, I.M. Kiem, and E. Rubin, J. Am. Geriat. Soc. 22:167 (1974).
Thompson, S.W., Q.L. Hartwig, M. Atik, M.A. Fox, and I. Cohn, Toxicol. Appl. Pharmacol. 5:306 (1963).
Henly, A.A., Analyst 82:286 (1957).
Sperry, W.M., and M. Webb, J. Biol. Chem. 187:97 (1950).
Carroll, N.V., R.W. Longley, and J.H. Roe, Ibid. 220:583 (1956).
Strecker, H.J., in “Methods in Enzymology,” Vol. II, Edited by S.P. Colowick and N.O. Kaplan, Academic Press, Inc., New York, NY p. 220.
Bonnichsen, R., Ibid. in “Methods in Enzymology,” Vol. II, Edited by S.P. Colowick and N.O. Kaplan, Academic Press, Inc., New York, NY p. 781.
Swanson, M.A., Ibid. in “Methods in Enzymology,” Vol. II, Edited by S.P. Colowick and N.O. Kaplan, Academic Press, Inc., New York, NY p. 541.
Amador, E., L.E. Dorlman, and W.E.C. Wacker, Clin. Chem. 9:391 (1963).
King, J., J. Med. Lab. Technol. 17:1 (1960).
Miettinen, T.A., E.H. Ahrens, and S.M. Grundy, J. Lipid Res. 6:411 (1965).
Grundy, S.M., E.H. Ahrens, and T.A. Miettinen, Ibid. 6:397 (1965).
Zilversmit, D.B., Proc. Soc. Exp. Biol. Med. 140:862 (1972).
Reddy, J., D. Svoboda, and D. Azarnoff, Biochem. Biophys. Res. Commun. 52:537 (1973).
Platt, D.S., and B.L. Cockrill, Biochem. Pharmacol. 16:2257 (1967).
Platt, D.S., and J.M. Thorp, Ibid. 15:915 (1966).
Malinow, M.R., P. McLaughlin, and A. Perley, Atherosclerosis 15:31 (1972).
Kritchevsky, D., H.K. Kim, and S.A. Tepper, Proc. Soc. Exp. Biol. Med. 136:1216 (1971).
Miettinen, T.A., Atherosclerosis 15:163 (1972).
Author information
Authors and Affiliations
About this article
Cite this article
Barnhart, J.W., Rytter, D.J. & Molello, J.A. An overview of the biochemical pharmacology of probucol. Lipids 12, 29–33 (1977). https://doi.org/10.1007/BF02532968
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02532968